Product Information
POTASSIUM CL ER 8 MEQ TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1020 per EA under NDC 16571084250. Its NADAC has been published 55 times since Aug 6, 2025.
FDA first approved this application on Dec 19, 2023. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571084250
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217412FDA Approved
12/19/2023
TE Code
AB2
On Market Since
2/13/2025
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 8 MEQ TABLET has been published 55 times since Aug 6, 2025, and over the history we have for it it has declined 26.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1020 per EA |
|---|---|
| All-time high | $0.1413 (Sep 10, 2025) |
| All-time low | $0.1020 (Aug 19, 2026) |
| 52-week high | $0.1413 |
| 52-week low | $0.1020 |
| Median price | $0.1369 |
| Average price | $0.1296 |
| Largest weekly change | -8.3% (Feb 18, 2026) |
| Weeks tracked | 55 |
| Tracking since | Aug 6, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 8 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1020 per EA (NDC 16571084250), effective Aug 19, 2026.
How has the price of POTASSIUM CL ER 8 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has declined 26.9%. It has been tracked across 55 weekly CMS publications since Aug 6, 2025.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ TABLET?
Since Aug 6, 2025, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has ranged from a low of $0.1020 (Aug 19, 2026) to a high of $0.1413 (Sep 10, 2025), with a median of $0.1369 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 8 MEQ TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures POTASSIUM CL ER 8 MEQ TABLET?
POTASSIUM CL ER 8 MEQ TABLET (NDC 16571084250) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.